[1] 汤新慧, 高静. 实验性肝损伤的损伤机制[J]. 中西医结合肝病杂志, 2002, 12(1): 53-55.
[2] Zhang J X, Zhang Y P, Wu Q N, et al. Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes[J]. Endocrine, 2015, 48(1): 135-142.
[3] Shi Y, Evans J E, Rock K L. Molecular identification of a danger signal that alerts the immune system to dying cells[J]. Nature, 2003, 425(6957): 516-521.
[4] Behrens M D, Wagner W M, Krco C J, et al. The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity[J]. Blood, 2008, 111(3): 1472-1479.
[5] Choi Y J, Yoon Y, Lee K Y, et al. Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis[J]. Faseb I, 2014, 28(7): 3197-3204.
[6] Krasnokutsky S, Romero A G, Bang D, et al. Impaired arterial responsiveness in untreated gout patients compared with healthy non-gout controls: association with serum urate and C-reactive protein[J]. Clin Rheumatol, 2018, 37(7): 1903-1911.
[7] Toprover M, Shah B, Oh C, et al. Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study[J]. Arthritis Res Ther, 2020, 22(1): 169.
[8] 李红艳, 秦历杰, 李静宇, 等. 降尿酸治疗对脑梗死患者血管内皮功能的影响[J]. 中华急诊医学杂志, 2021, 30(6): 744-748.
[9] Zhang M, Wang Y, Wang K, et al. Association between uric acid and the prognosis of acute ischemic stroke: a systematic review and meta-analysis[J]. Nutr Metab Cardiovasc Dis, 2021, 31(11): 3016-3023.
[10] Zhou Z, Liang Y, Lin J, et al. Serum uric acid concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis[J]. Atherosclerosis, 2018, 275: 352-358.
[11] 王常屹, 吴波. 尿酸与脑梗死发病及预后相关性的研究进展[J]. 中华脑血管病杂志(电子版), 2021, 15(3): 135-139.
[12] Wang M, Wu J, Jiao H, et al. Enterocyte synthesizes and secrets uric acid as antioxidant to protect against oxidative stress via the involvement of Nrf pathway[J]. Free Radic Biol Med, 2022, 179: 95-108.
[13] 周红权, 周世英, 宋环平, 等. 失代偿期肝硬化患者血尿酸水平的变化[J]. 中国医师杂志, 2012, (z1): 112-114.
[14] 陈卓鹏. 肝硬化患者血尿酸检测水平分析[J]. 中国热带医学, 2005, 5(6): 1256,70.
[15] Sautin Y Y, Johnson R J. Uric acid: the oxidant-antioxidant paradox[J]. Nucleosides Nucleotides Nucleic Acids, 2008, 27(6): 608-619.
[16] 杨艳. 尿酸对肝细胞氧化应激及线粒体功能影响的研究[D]. 2016.
[17] Huang J F, Yeh M L, Yu M L, et al. Hyperuricemia inversely correlates with disease severity in taiwanese nonalcoholic steatohepatitis patients[J]. PLoS One, 2015, 10(10): e0139796.
[18] Jaruvongvanich V, Ahujia W, Wijarnpreecha K, et al. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2017, 29(6): 694-697.
[19] Zhu J Z, Dai Y N, Wang Y M, et al. Prevalence of nonalcoholic fatty liver disease and economy[J]. Dig Dis Sci, 2015, 60(11): 3194-3202.
[20] Mantovani A, Ballestri S, Lonardo A, et al. Cardiovascular disease and myocardial abnormalities in nonalcoholic fatty liver disease[J]. Dig Dis Sci, 2016, 61(5): 1246-1267.
[21] Jaruvongvanich V, Ahuja W, Wirunsawanya K, et al. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis[J]. Eur J Gastroenterol Hepatol, 2017, 29(9): 1031-1035.
[22] Marchesini G, Marzocchi R. Metabolic syndrome and NASH[J]. Clin Liver Dis, 2007, 11(1): 105-117, ix.
[23] Martins V M, Ziegelmann P K, Ferrari F, et al. Thiazide diuretics alone or combined with potassium-sparing diuretics to treat hypertension: a systematic review and network meta-analysis of randomized controlled trials[J]. J Hypertens, 2023, 41(7): 1108-1116.
[24] Hong T, Zhang M, Fan J. Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients[J]. Cochrane Database Syst Rev, 2015, 2015(10): Cd009698.
[25] Ferrer P, Amelio J, Ballarín E, et al. Systematic review and meta-analysis: macrolides-and amoxicillin/clavulanate-induced acute liver injury[J]. Basic Clin Pharmacol Toxicol, 2016, 119(1): 3-9.
[26] Masson W, Lobo M, Masson G, et al. Statin use in patients with elevated serum hepatic transaminases at baseline: a meta-analysis[J]. Nutr Metab Cardiovasc Dis, 2021, 31(5): 1357-1364.
[27] Averbukh L D, Turshudzhyan A, Wu D C, et al. Statin-induced liver injury patterns: a clinical review[J]. J Clin Transl Hepatol, 2022, 10(3): 543-552.
[28] 徐贵, 张晓艳, 杨伟霞. 总胆汁酸、尿酸和胆碱酯酶检测在乙型肝炎肝硬化中的意义[J]. 国际检验医学杂志, 2016, 37(12): 1724-1726.
[29] 秦蕾, 周黎黎. 肝硬化失代偿患者血尿酸水平的变化及意义[J]. 临床和实验医学杂志, 2012, 11(5): 343-344.
[30] Björnsson H K, Björnsson E S. Drug-induced liver injury: pathogenesis, epidemiology, clinical features, and practical management[J]. Eur J Intern Med, 2022, 97: 26-31.
[31] 王悠扬, 张冰清, 张昀, 等. 慢性丙型肝炎与尿酸水平异常的相关性研究进展[J]. 医药导报, 2023, 42(2): 177-181.
[32] 刘婷, 王臣廷, 刘美晓, 等. 2型糖尿病合并非酒精性脂肪性肝病患者肝纤维化与血尿酸水平的关系[J]. 临床肝胆病杂志, 2020, 36(6): 1320-1324.
[33] Liu J, Martins P N, Bhat M, et al. Biomarkers and predictive models of early allograft dysfunction in liver transplantation-A systematic review of the literature, meta-analysis, and expert panel recommendations[J]. Clin Transplant, 2022, 36(10): e14635. |
